STAGE: Stay Healthy Through Ageing
The STAGE project (https://stage-healthyageing.eu/The STAGE project (https://stage-healthyageing.eu/) aims to understand, predict and prevent ageing with multi-morbidity and to provide person-centred care solutions for the early diagnosis, screening, treatment and long-term management of multi-morbidity.
The focus is on demonstrating the importance and feasibility of a life-course approach to prevent accelerated ageing defined by the accumulation of multi-morbidity and to provide evidence-based solutions to support healthcare transformation. The approach capitalises on European collaborations of longitudinal cohorts and biobanks across the life course, using exposome and disease network trajectory analysis, as well as the biology of ageing, to explore how a person develops ageing with multimorbidity. The project objectives integrate an ethical, social, historical and infrastructural framework; environmental, epidemiological and biological life-course approaches; artificial intelligence-driven integrated person-centred solutions and applications; cohort-based clinical trials; and a FAIR (findable, accessible, interoperable and reusable) life-course health and geospatial data portal with robust management, dissemination, engagement and exploitation activities.
Ultimately, STAGE will create solutions for agile, high quality, person-centred health and care services that are life-course and gender sensitive, needs-based and designed to increase resilience and participation.
Promotion
Subproject
The TUM ethics team is leading WP2 “Ethical, legal, social, historical, and infrastructural preparedness for age-friendly healthcare systems and societies”, in collaboration with colleagues from the University of Haifa and the Ruhr University of Bochum.
WP2 aims to:
- Identify the barriers and opportunities for policies and practices across the life course to prevent the risk of ageing with multi-morbidity;
- Co-create and reach consensus amongst experts on the factors promoting or hindering ageing without multi-morbidity. This will include recommendations on (i) the best practices and mechanisms to streamline care across all healthcare settings, and (ii) the ethical and practical considerations in personalised medicine, genetic prediction, artificial intelligence and healthcare technology for the promotion of healthy ageing;
- Propose ethical recommendations and guidelines for practices and policies for person-centred applications and solutions for clinicians and ageing citizens;
- Test the applicability of the recommendations for life-course prevention of ageing with multi-morbidity for citizens and healthcare and for policies.
In addition, the TUM ethics team is acting as the project´s ethics representative and will be responsible for continuous monitoring of ethical, legal and social aspects and for flagging any potential issues, using the embedded ethics approach.
Mail: stuart.mclennan@tum.de
Project Management:
Stuart McLennan
Period:
01.01.2024-31.12.2029
Project Type:
EU consortium
Funding source:
EU project Horizon
EN 
DE